Abstract:Background:Depression is a serious psychiatric disorder that creates a major public health burden of disease and disability. It is quite widespread;approximately 16% of individuals in the United States have suffered from clinical depression during their lifetime. While antidepressants have been available for several decades,most of them are not totally effective. New approaches to clinically treating depression are thus needed,and the molecular and cellular mechanisms underlying the pathophysiology of depression could provide a new therapeutic target. Cyclin-dependent kinase 5 (Cdk5),is a proline-directed serine/threonine kinase that is highly active in the brain and is important for the development of the central nervous system. Cdk5 has been implicated in synaptic plasticity,which underlies learning and memory,as well as neuropsychiatric pathologies like depression and bipolar disorder. Recently,it also has been reported that inhibition of Cdk5 activity in the hippocampus facilitates extinction of learned contextual fear memory,suggesting that Cdk5 could be a potential target for treatment of emotional disorders. However,hippocampal Cdk5’s potential role in the development of depressive diseases has not been examined.Objectives:To investigate the possible roles that Cdk5/p35 might play in the development of depressive-like symptoms,using the chronic mild stress rat model. Methods:Two hundred and ninety-two male Sprague-Dawley rats (weighing 200-220 g at the start of the study) were individually housed under a constant temperature (23±s 2 degrees Celsius) and maintained on a 12 h light/dark cycle with free access to food and water. In order to examine the effects of Cdk5/p35 activity in hippocampus on depressive-like behavior,rats were subjected to the chronic mild stress procedure for 3 weeks. Subsequently,the depressive-like behaviors including sucrose preference,bodyweight increase and locomotor activity were examined;Cdk5 kinase activity was measured by an in vitro phosphorylation assay,and membrane and cytosolic p35 levels were detected by Western blot analysis. In order to investigate whether Cdk5 is functionally related to the depressive-like symptoms elicited by the CMS procedure,Buty,a Cdk5 inhibitor,was infused into DG,CA1 and CA3 subfield,respectively. Over the next 3 weeks,they received injections in DG,CA1 or CA3 on days 1,7,14 and 21,as detailed in a previous study. The control groups received intra-DG,CA1 or CA3 injection of saline containing 0.2% DMSO or different doses of Buty (25,50 and 100 ng). The chronic mild stress groups were given intra-DG,CA1 or CA3 injections of saline containing 0.2% DMSO and different doses of Buty (25,50 and 100 ng) during the 3 weeks of chronic mild stress. Each intracranial injection was administrated between 8.00-10.00 am,1 h prior to stress exposure to the stressor. The day after the last stress exposure,the sucrose preference test was performed and then the animals were decapitated. Subsequently,bilateral tissue punches from CA1,CA3 and DG (16 gauge) were obtained. Proteins were extracted for kinase activity measurement and Western blot assay. The subsequent experiment was designed to determine the role p35 translocation plays in the actions of antidepressants. Four groups of rats (n=8 per group) were used to examine effects of the antidepressant venlafaxine on DG p35 translocation using a 2×2 design with the between-subject factors of Group (Control or CMS) and Treatment (vehicle or venlafaxine). The other four groups of rats (n=8 per group) were used to examine the effects of the antidepressant mirtazapine on DG p35 translocation using a 2×2 design,with the between-subject factors Group (Control or CMS) and Treatment (vehicle or mirtazapine). Intraperitoneal drug or vehicle injections were performed for 21 consecutive days in both the control and CMS groups. The day after the last stress exposure,the sucrose preference test was performed and the animals were decapitated. Subsequently,bilateral DG tissue punches (16 gauge) were obtained. The cytoplasmic and membrane protein levels were measured by Western blot assay. Results:CMS increased hippocampal Cdk5 activity,which was accompanied by an upregulation of membrane p35,a Cdk5 activator,and a reduction of cytosolic p35 in the dentate gyrus (DG). Microinjection of a Cdk5 inhibitor,butyrolactone,in DG,but not in CA1 or CA3,reversed the depressive-like behaviors induced by CMS. A negative linear correlation was found between sucrose preference,bodyweight increase and the membrane p35 level in DG. Chronic treatment with antidepressants venlafaxine and mirtazapine,but not the antipsychotic aripiprazole,prevented the aberrant translocation of p35 induced by CMS in DG. Conclusion:Our results revealed that the development of depressive-like behavior was associated with increased Cdk5 activity through p35 translocation from the cytosol to the membrane in DG. These findings suggest that hippocampal Cdk5/p35 complex mediated the depressive-like behavior induced by CMS;thus,Cdk5 could be a novel target for therapeutic treatment of major depression.

Expression and Activity of Cdk5/p35 in Vc of Rats

The Expression of Cdk5, p35, p39, and Cdk5 Kinase Activity in Developing, Adult, and Aged Rat Brains

P25/cdk5 is Partially Involved in Neuronal Injury Induced by Radiofrequency Electromagnetic Field Exposure.

Cdk5/P35 Regulates Neurotransmitter Release Through Phosphorylation and Downregulation of P/Q-Type Voltage-Dependent Calcium Channel Activity

Expression Profiles Analysis of Differential Genes in Rat Visual Cortex Depending Upon Postnatal Days by Microarray

Overexpression of CDK5 in Neural Stem Cells Facilitates Maturation of Embryonic Neurocytes Derived from Rats in Vitro

Vps35 Regulates Developing Mouse Hippocampal Neuronal Morphogenesis by Promoting Retrograde Trafficking of Bace1

Pkc Delta Regulates Cortical Radial Migration By Stabilizing The Cdk5 Activator P35

Role of p35/Cdk5 in preplate splitting in the developing cerebral cortex

Expression of Protocadherin‐γc4 Protein in the Rat Brain

Increased Cdk5/P35 Activity In The Dentate Gyrus Mediates Depressive-Like Behaviour In Rats

The Presence of Active Cdk5 Associated with P35 in Astrocytes and Its Important Role in Process Elongation of Scratched Astrocyte.

The different roles of cyclinD1-CDK4 in STP and mGluR-LTD during the postnatal development in mice hippocampus area CA1

The Effect of P85 on Neuronal Proliferation and Differentiation During Development of Mouse Cerebral Cortex.

CYCLIN-DEPENDENT KINASE 5 IN THE DENTATE GYRUS MEDIATES DEPRESSIVE-LIKE BEHAVIOR IN RATS

Inhibition of Cdk5 in PV Neurons Reactivates Experience-Dependent Plasticity in Adult Visual Cortex

Cdk5 activation promotes Cos-7 cells transition towards neuronal-like cells

Cyclin-dependent Kinase 5 Regulates Cortical Neurotransmission and Neural Circuits Associated with Motor Control in the Secondary Motor Cortex in the Mouse

Expression of Cyclin-dependent Kinase 5 on Hippocampal Neurons in Diabetic Rats

P85 regulates neuronal migration through affecting neuronal morphology during mouse corticogenesis

Expression of NCAM in Postnatal Development of Rat Visual Cortex